Hawkins Richard J
Insider CIK 1307632 · CNSY Director · (LUMO) Chief Executive Officer, Director · SVRA Director · SCLN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CNSY CERENOME, INC. | M Exercise deriv | 2026-10-01 | 2026-10-01 | 921 | — | $0 | 1,843 | SEC↗ |
| CNSY CERENOME, INC. | M Exercise | 2026-10-01 | 2026-10-01 | 921 | — | $0 | 2,450 | SEC↗ |
| PSTV PLUS THERAPEUTICS, INC. | M Exercise deriv | 2026-07-01 | 2026-07-01 | 922 | — | $0 | 2,764 | SEC↗ |
| PSTV PLUS THERAPEUTICS, INC. | M Exercise | 2026-07-01 | 2026-07-01 | 922 | — | $0 | 1,529 | SEC↗ |
| PSTV PLUS THERAPEUTICS, INC. | A Award deriv | 2026-05-14 | 2026-05-18 | 3,686 | — | $0 | 3,686 | SEC↗ |
| PSTV PLUS THERAPEUTICS, INC. | A Award deriv | 2026-05-14 | 2026-05-18 | 3,686 | — | $0 | 3,686 | SEC↗ |
| SVRA Savara Inc | A Award | 2025-12-09 | 2025-12-11 | 40,000 | — | $0 | 161,326 | SEC↗ |
| SVRA Savara Inc | M Exercise deriv | 2025-11-14 | 2025-11-17 | 5,860 | — | $0 | 0 | SEC↗ |
| SVRA Savara Inc | M Exercise | 2025-11-14 | 2025-11-17 | 5,860 | $1.46 | $8.6K | 121,326 | SEC↗ |
| PSTV PLUS THERAPEUTICS, INC. | A Award deriv | 2025-08-13 | 2025-08-15 | 397,794 | — | $0 | 397,794 | SEC↗ |
| SVRA Savara Inc | P Buy | 2025-06-20 | 2025-06-23 | 48,225 | $2.04 | $98.4K | 115,466 | SEC↗ |
| PSTV PLUS THERAPEUTICS, INC. | A Award deriv | 2025-02-18 | 2025-02-20 | 40,122 | — | $0 | 40,122 | SEC↗ |
| SVRA Savara Inc | S Sale | 2024-12-16 | 2024-12-16 | 8,000 | $3.32 | $26.6K | 67,241 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 28,475 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 35,400 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 135,000 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 35,400 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 35,400 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 19,624 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer | 2024-12-12 | 2024-12-13 | 4,469 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer | 2024-12-12 | 2024-12-13 | 753,093 | — | $0 | 0 | SEC↗ |
| SVRA Savara Inc | A Award | 2024-12-12 | 2024-12-16 | 40,000 | — | $0 | 75,241 | SEC↗ |
| PSTV PLUS THERAPEUTICS, INC. | P Buy | 2024-09-13 | 2024-09-17 | 4,000 | $1.50 | $6.0K | 15,188 | SEC↗ |
| PSTV PLUS THERAPEUTICS, INC. | P Buy | 2024-09-12 | 2024-09-16 | 6,285 | $1.35 | $8.5K | 11,188 | SEC↗ |
| PSTV PLUS THERAPEUTICS, INC. | A Award deriv | 2024-09-11 | 2024-09-12 | 3,650 | — | $0 | 3,650 | SEC↗ |
| PSTV PLUS THERAPEUTICS, INC. | A Award deriv | 2024-05-08 | 2024-05-10 | 9,804 | — | $0 | 9,804 | SEC↗ |
| PSTV PLUS THERAPEUTICS, INC. | P Buy | 2024-05-08 | 2024-05-10 | 4,902 | $2.04 | $10.0K | 4,903 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2024-04-01 | 2024-04-03 | 35,400 | — | $0 | 35,400 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award | 2024-04-01 | 2024-04-03 | 4,500 | $2.84 | $12.8K | 754,615 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | F Tax w/h | 2024-04-01 | 2024-04-03 | 1,522 | $2.84 | $4.3K | 753,093 | SEC↗ |
| PSTV PLUS THERAPEUTICS, INC. | A Award deriv | 2024-02-22 | 2024-02-26 | 2,250 | — | $0 | 2,250 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | F Tax w/h | 2024-02-01 | 2024-02-05 | 690 | $3.01 | $2.1K | 750,115 | SEC↗ |
| SVRA Savara Inc | A Award | 2023-12-14 | 2023-12-15 | 22,500 | — | $0 | 35,241 | SEC↗ |
| SVRA Savara Inc | M Exercise deriv | 2023-12-11 | 2023-12-12 | 10,841 | — | $0 | 0 | SEC↗ |
| SVRA Savara Inc | M Exercise | 2023-12-11 | 2023-12-12 | 10,841 | $0.82 | $8.9K | 12,741 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | F Tax w/h | 2023-04-01 | 2023-04-04 | 1,522 | $3.31 | $5.0K | 750,805 | SEC↗ |
| PSTV PLUS THERAPEUTICS, INC. | P Buy | 2023-03-03 | 2023-03-06 | 1 | $1000.00 | $1.0K | 1 | SEC↗ |
| PSTV PLUS THERAPEUTICS, INC. | A Award deriv | 2023-02-15 | 2023-02-17 | 20,182 | — | $0 | 20,182 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2023-02-01 | 2023-02-03 | 35,400 | — | $0 | 35,400 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award | 2023-02-01 | 2023-02-03 | 4,500 | $3.52 | $15.8K | 752,743 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | F Tax w/h | 2023-02-01 | 2023-02-03 | 416 | $3.52 | $1.5K | 752,327 | SEC↗ |
| SVRA Savara Inc | A Award deriv | 2022-12-13 | 2022-12-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SVRA Savara Inc | M Exercise deriv | 2022-12-07 | 2022-12-08 | 1,172 | — | $0 | 0 | SEC↗ |
| SVRA Savara Inc | M Exercise | 2022-12-07 | 2022-12-08 | 1,172 | $0.65 | $762 | 1,900 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | P Buy | 2022-09-23 | 2022-09-23 | 208 | $8.80 | $1.8K | 4,469 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | P Buy | 2022-09-21 | 2022-09-23 | 2,214 | $8.84 | $19.6K | 4,261 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | P Buy | 2022-09-20 | 2022-09-21 | 1,506 | $8.75 | $13.2K | 2,047 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | P Buy | 2022-09-19 | 2022-09-21 | 541 | $8.65 | $4.7K | 541 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | F Tax w/h | 2022-04-01 | 2022-04-05 | 1,466 | $9.23 | $13.5K | 748,243 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2022-02-01 | 2022-02-03 | 35,400 | — | $0 | 35,400 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | F Tax w/h | 2022-02-01 | 2022-02-03 | 173 | $10.02 | $1.7K | 749,709 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award | 2022-02-01 | 2022-02-03 | 4,500 | $10.02 | $45.1K | 749,882 | SEC↗ |
| SVRA Savara Inc | A Award deriv | 2021-12-14 | 2021-12-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SVRA Savara Inc | M Exercise deriv | 2021-12-13 | 2021-12-14 | 728 | — | $0 | 0 | SEC↗ |
| SVRA Savara Inc | M Exercise | 2021-12-13 | 2021-12-14 | 728 | $0.55 | $400 | 728 | SEC↗ |
| PSTV PLUS THERAPEUTICS, INC. | A Award deriv | 2021-06-11 | 2021-06-11 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PSTV PLUS THERAPEUTICS, INC. | A Award deriv | 2021-06-11 | 2021-06-11 | 6,336 | — | $0 | 6,336 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | F Tax w/h | 2021-04-01 | 2021-04-05 | 1,522 | $12.25 | $18.6K | 745,382 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2021-02-01 | 2021-02-03 | 28,475 | — | $0 | 28,475 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award | 2021-02-01 | 2021-02-03 | 2,329 | — | $0 | 746,904 | SEC↗ |
| SVRA Savara Inc | A Award deriv | 2020-12-16 | 2020-12-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PSTV PLUS THERAPEUTICS, INC. | A Award deriv | 2020-06-25 | 2020-06-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2020-04-01 | 2020-04-03 | 135,000 | — | $0 | 135,000 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award | 2020-04-01 | 2020-04-03 | 25,000 | — | $0 | 744,575 | SEC↗ |
| SVRA Savara Inc | A Award deriv | 2019-12-20 | 2019-12-26 | 12,000 | — | $0 | 12,000 | SEC↗ |
| SVRA Savara Inc | S Sale | 2019-05-15 | 2019-05-16 | 10,409 | $11.16 | $116.2K | 0 | SEC↗ |
| SVRA Savara Inc | M Exercise deriv | 2019-05-14 | 2019-05-16 | 21,682 | — | $0 | 0 | SEC↗ |
| SVRA Savara Inc | M Exercise deriv | 2019-05-14 | 2019-05-16 | 444 | — | $0 | 728 | SEC↗ |
| SVRA Savara Inc | M Exercise deriv | 2019-05-14 | 2019-05-16 | 2,288 | — | $0 | 0 | SEC↗ |
| SVRA Savara Inc | M Exercise deriv | 2019-05-14 | 2019-05-16 | 586 | — | $0 | 0 | SEC↗ |
| SVRA Savara Inc | S Sale | 2019-05-14 | 2019-05-16 | 14,591 | $11.07 | $161.5K | 10,409 | SEC↗ |
| SVRA Savara Inc | M Exercise | 2019-05-14 | 2019-05-16 | 444 | $0.55 | $244 | 25,000 | SEC↗ |
| SVRA Savara Inc | M Exercise | 2019-05-14 | 2019-05-16 | 2,288 | $0.52 | $1.2K | 24,556 | SEC↗ |
| SVRA Savara Inc | M Exercise | 2019-05-14 | 2019-05-16 | 586 | $0.52 | $305 | 22,268 | SEC↗ |
| SVRA Savara Inc | M Exercise | 2019-05-14 | 2019-05-16 | 21,682 | $0.52 | $11.3K | 21,682 | SEC↗ |
| SVRA Savara Inc | A Award deriv | 2018-12-13 | 2018-12-14 | 12,000 | — | $0 | 12,000 | SEC↗ |
| CTYX CYTORI THERAPEUTICS, INC. | X Exercise deriv | 2018-07-25 | 2018-07-27 | 10 | — | $0 | 35 | SEC↗ |
| CTYX CYTORI THERAPEUTICS, INC. | X Exercise deriv | 2018-07-25 | 2018-07-27 | 10,500 | — | $0 | 10,500 | SEC↗ |
| CTYX CYTORI THERAPEUTICS, INC. | X Exercise deriv | 2018-07-25 | 2018-07-27 | 10 | — | $0 | 0 | SEC↗ |
| SVRA Savara Inc | A Award deriv | 2017-12-17 | 2017-12-19 | 3,750 | — | $0 | 3,750 | SEC↗ |
| CTYX CYTORI THERAPEUTICS, INC. | X Exercise deriv | 2017-11-28 | 2017-11-29 | 3 | — | $0 | 0 | SEC↗ |
| CTYX CYTORI THERAPEUTICS, INC. | X Exercise deriv | 2017-11-28 | 2017-11-29 | 5,400 | — | $0 | 5,400 | SEC↗ |
| CTYX CYTORI THERAPEUTICS, INC. | X Exercise deriv | 2017-11-28 | 2017-11-29 | 3 | — | $0 | 3 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $5.14 | $154.2K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $6.05 | $181.5K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $4.40 | $132.0K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $0.28 | $8.4K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $2.03 | $60.9K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $6.08 | $182.4K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer | 2017-10-13 | 2017-10-16 | 24,363 | $11.18 | $272.4K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2017-06-08 | 2017-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CTYX CYTORI THERAPEUTICS, INC. | A Award deriv | 2017-01-26 | 2017-01-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2016-08-12 | 2016-08-16 | 30,000 | — | $0 | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2016-08-12 | 2016-08-16 | 30,000 | — | $0 | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2016-08-12 | 2016-08-16 | 30,000 | — | $0 | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2016-08-12 | 2016-08-16 | 30,000 | — | $0 | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | S Sale | 2016-08-12 | 2016-08-16 | 30,000 | $10.37 | $311.1K | 24,363 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2016-08-12 | 2016-08-16 | 30,000 | $3.01 | $90.3K | 54,363 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2016-08-12 | 2016-08-16 | 30,000 | $2.23 | $66.9K | 54,363 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | S Sale | 2016-08-12 | 2016-08-16 | 30,000 | $10.37 | $311.1K | 24,363 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2016-08-12 | 2016-08-16 | 30,000 | $1.75 | $52.5K | 54,363 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | S Sale | 2016-08-12 | 2016-08-16 | 30,000 | $10.37 | $311.1K | 24,363 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2016-08-12 | 2016-08-16 | 30,000 | $2.61 | $78.3K | 54,363 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | S Sale | 2016-08-12 | 2016-08-16 | 30,000 | $10.37 | $311.1K | 24,363 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | X Exercise deriv | 2016-06-15 | 2016-06-15 | 3,356 | — | $0 | 0 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | X Exercise deriv | 2016-06-15 | 2016-06-15 | 1,678 | — | $0 | 1,678 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | X Exercise | 2016-06-15 | 2016-06-15 | 3,356 | — | $0 | 8,435 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2016-06-09 | 2016-06-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2016-05-05 | 2016-05-09 | 30,000 | — | $0 | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | F Tax w/h | 2016-05-05 | 2016-05-09 | 5,637 | $13.09 | $73.8K | 24,363 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2016-05-05 | 2016-05-09 | 30,000 | $2.46 | $73.8K | 30,000 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award deriv | 2016-01-04 | 2016-01-04 | 53,820 | — | $0 | 220,950 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2015-06-11 | 2015-06-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2015-06-01 | 2015-06-02 | 4,570 | — | $0 | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2015-06-01 | 2015-06-02 | 4,570 | $3.27 | $14.9K | 4,570 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | S Sale | 2015-06-01 | 2015-06-02 | 4,570 | $9.27 | $42.4K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2015-05-29 | 2015-06-01 | 10,430 | — | $0 | 4,570 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2015-05-29 | 2015-06-01 | 10,430 | $3.27 | $34.1K | 10,430 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | S Sale | 2015-05-29 | 2015-06-01 | 10,430 | $9.32 | $97.2K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | S Sale | 2015-05-26 | 2015-05-26 | 11,982 | $9.44 | $113.1K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | S Sale | 2015-05-21 | 2015-05-26 | 3,700 | $9.71 | $35.9K | 11,982 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | S Sale | 2015-05-14 | 2015-05-18 | 18,727 | $9.16 | $171.5K | 15,682 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award | 2015-05-08 | 2015-05-14 | 34,228 | — | $0 | 34,228 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award deriv | 2015-02-13 | 2015-02-13 | 25,000 | — | $0 | 167,130 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | S Sale | 2014-12-11 | 2014-12-11 | 740 | $8.82 | $6.5K | 34,409 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | S Sale | 2014-12-10 | 2014-12-11 | 14,851 | $8.79 | $130.5K | 35,149 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2014-09-29 | 2014-10-01 | 50,000 | — | $0 | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2014-09-29 | 2014-10-01 | 50,000 | $4.55 | $227.5K | 50,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2014-06-12 | 2014-06-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award | 2014-05-19 | 2014-05-20 | 5,191 | — | $0 | 15,741 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award deriv | 2014-01-01 | 2014-01-03 | 16,030 | — | $0 | 142,130 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award | 2014-01-01 | 2014-01-03 | 10,550 | — | $0 | 10,550 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2013-06-27 | 2013-06-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award deriv | 2013-01-01 | 2013-01-03 | 6,100 | — | $0 | 126,100 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award | 2013-01-01 | 2013-01-03 | 6,100 | — | $0 | 6,100 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2012-06-07 | 2012-06-08 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award deriv | 2012-01-01 | 2012-01-04 | 15,000 | — | $0 | 120,000 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award | 2012-01-01 | 2012-01-04 | 10,000 | — | $0 | 20,085 | SEC↗ |